Glenmark Pharmaceuticals to Attend PL Capital Emerging Titans Conference
Glenmark Pharmaceuticals Ltd 路 Intimation 路 21 Sept 2026, 8:28 pm
Glenmark Pharmaceuticals to Attend PL Capital Emerging Titans Conference Glenmark Pharmaceuticals Ltd. announced under Regulation 30 of SEBI LODR that it will participate in the PL Capital - Emerging Titans 2026 Conference on 29th Sep'26 in Mumbai. The physical event will comprise both group and one-on-one institutional investor and analyst interactions. The company confirmed that no unpublished price sensitive information (UPSI) will be shared during the scheduled meetings.
Original exchange filing (PDF)
More announcements from Glenmark Pharmaceuticals Ltd
- Ichnos Glenmark Innovation (IGI) announces IND submission to US FDA for ISB 2301 路 18 Nov 2026
- Glenmark Pharmaceuticals Inc., USA Launches Authorised Generic of INLYTA (axitinib) Tablets, 1 mg and 5mg 路 16 Nov 2026
- Schedule of Schedule of Analyst/ Institutional Investor Meetings 路 10 Nov 2026
- Initmation of Schedule of Analyst/ Institutional Investor Meetings 路 10 Nov 2026
- Intimation of Schedule of Analyst/ Institutional Investor Meetings 路 10 Nov 2026
- Intimation of Schedule of Analyst / Institutional Investor Meetings 路 10 Nov 2026
- Transcript of the Earnings Call 路 09 Nov 2026
- Audio recording of Q2 FY 2026-27 Earnings Call held on November 06, 2026 路 06 Nov 2026
